<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Zhao Y</submitter><pubmed_abstract>Gain-of-function mutations of SHP2, especially D61Y and E76K, lead to the development of neoplasms in hematopoietic cells. Previously, we found that SHP2-D61Y and -E76K confer HCD-57 cells cytokine-independent survival and proliferation &lt;i>via&lt;/i> activation of MAPK pathway. Metabolic reprogramming is likely to be involved in leukemogenesis led by mutant SHP2. However, detailed pathways or key genes of altered metabolisms are unknown in leukemia cells expressing mutant SHP2. In this study, we performed transcriptome analysis to identify dysregulated metabolic pathways and key genes using HCD-57 transformed by mutant SHP2. A total of 2443 and 2273 significant differentially expressed genes (DEGs) were identified in HCD-57 expressing SHP2-D61Y and -E76K compared with parental cells as the co</pubmed_abstract><journal>Frontiers in oncology</journal><pagination>1090542</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9922838</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Transcriptome analysis reveals effects of leukemogenic SHP2 mutations in biosynthesis of amino acids signaling.</pubmed_title><pmcid>PMC9922838</pmcid><pubmed_authors>He C</pubmed_authors><pubmed_authors>Zhang D</pubmed_authors><pubmed_authors>Guo Y</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Chang Z</pubmed_authors><pubmed_authors>Chen C</pubmed_authors><pubmed_authors>Hu B</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors><pubmed_authors>Peng Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Transcriptome analysis reveals effects of leukemogenic SHP2 mutations in biosynthesis of amino acids signaling.</name><description>Gain-of-function mutations of SHP2, especially D61Y and E76K, lead to the development of neoplasms in hematopoietic cells. Previously, we found that SHP2-D61Y and -E76K confer HCD-57 cells cytokine-independent survival and proliferation &lt;i>via&lt;/i> activation of MAPK pathway. Metabolic reprogramming is likely to be involved in leukemogenesis led by mutant SHP2. However, detailed pathways or key genes of altered metabolisms are unknown in leukemia cells expressing mutant SHP2. In this study, we performed transcriptome analysis to identify dysregulated metabolic pathways and key genes using HCD-57 transformed by mutant SHP2. A total of 2443 and 2273 significant differentially expressed genes (DEGs) were identified in HCD-57 expressing SHP2-D61Y and -E76K compared with parental cells as the co</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2026-05-29T03:30:45.777Z</modification><creation>2024-12-03T17:16:29.87Z</creation></dates><accession>S-EPMC9922838</accession><cross_references><pubmed>36793607</pubmed><doi>10.3389/fonc.2023.1090542</doi></cross_references></HashMap>